ABVC Biopharma: Funding, Investors & Team (Oct 2026)
ABVC Biopharma is a biopharmaceutical company in the early stages of clinical development. Its main goal is to identify and advance drugs and medical devices that are currently being developed. The company primarily focuses on utilizing its licensed technology to carry out proof-of-concept trials and undergo Phase II of the clinical development process. ABVC Biopharma specializes in botanically-based solutions that offer improved health outcomes by providing high efficacy while minimizing toxicity.
ABVC Biopharma has raised $1.8M across 1 funding round on record, the most recent an undisclosed round of $1.8M announced in Jul 2023.
That round is below the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
ABVC Biopharma Company Profile and Key Stats
Latest funding round on record: Jul 2023.
ABVC Biopharma Funding Rounds
ABVC Biopharma Founders and Leadership Team
No contact details are on record for this team yet.
ABVC Biopharma Funding Compared to Other Biotechnology Startups
ABVC Biopharma's latest round of $1.8M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like ABVC Biopharma in Biotechnology and Fremont
Companies Similar to ABVC Biopharma
Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…
Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
ABVC Biopharma Funding FAQs
What does ABVC Biopharma do?
ABVC Biopharma is a biopharmaceutical company in the early stages of clinical development. Its main goal is to identify and advance drugs and medical devices that are currently being developed. The company primarily focuses on utilizing its licensed technology to carry out proof-of-concept trials and undergo Phase II of the clinical development process. ABVC Biopharma specializes in botanically-based solutions that offer improved health outcomes by providing high efficacy while minimizing toxicity.
How much funding has ABVC Biopharma raised?
ABVC Biopharma has raised $1.8M across 1 round on record. The most recent is an undisclosed round of $1.8M announced in Jul 2023.
When did ABVC Biopharma last raise funding?
ABVC Biopharma's most recent funding round on record is an undisclosed round of $1.8M, announced in Jul 2023.
Who founded ABVC Biopharma?
FundedIQ lists Leeds Chow (Founder) at ABVC Biopharma.
Where is ABVC Biopharma headquartered?
ABVC Biopharma is based in Fremont, California, United States.
How many employees does ABVC Biopharma have?
ABVC Biopharma is in the 11-50 employee band.
How does ABVC Biopharma's funding compare to other Biotechnology startups?
ABVC Biopharma's latest round of $1.8M is below the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's ABVC Biopharma Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for ABVC Biopharma is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.